Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
88.08
+4.34 (5.18%)
At close: Feb 21, 2025, 4:00 PM
88.01
-0.07 (-0.08%)
After-hours: Feb 21, 2025, 7:32 PM EST
Novo Nordisk Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 290,403 | 232,261 | 176,954 | 140,800 | 126,946 | Upgrade
|
| Revenue Growth (YoY) | 25.03% | 31.26% | 25.68% | 10.91% | 4.04% | Upgrade
|
| Cost of Revenue | 43,560 | 35,319 | 28,424 | 23,658 | 20,932 | Upgrade
|
| Gross Profit | 246,843 | 196,942 | 148,530 | 117,142 | 106,014 | Upgrade
|
| Selling, General & Admin | 67,368 | 61,594 | 50,683 | 41,058 | 36,886 | Upgrade
|
| Research & Development | 40,072 | 31,075 | 23,263 | 17,199 | 15,462 | Upgrade
|
| Other Operating Expenses | -476 | -425 | -1,034 | -332 | -460 | Upgrade
|
| Operating Expenses | 106,964 | 92,244 | 72,912 | 57,925 | 51,888 | Upgrade
|
| Operating Income | 139,879 | 104,698 | 75,618 | 59,217 | 54,126 | Upgrade
|
| Interest Expense | -1,640 | -542 | -378 | -289 | -390 | Upgrade
|
| Interest & Investment Income | 1,838 | 1,069 | 239 | 231 | 337 | Upgrade
|
| Earnings From Equity Investments | -17 | 81 | -189 | -24 | 149 | Upgrade
|
| Currency Exchange Gain (Loss) | -1,023 | 1,652 | -4,651 | 344 | -747 | Upgrade
|
| Other Non Operating Income (Expenses) | -289 | -197 | -181 | -122 | -150 | Upgrade
|
| EBT Excluding Unusual Items | 138,748 | 106,761 | 70,458 | 59,357 | 53,325 | Upgrade
|
| Merger & Restructuring Charges | -978 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -17 | 37 | -587 | 296 | -195 | Upgrade
|
| Asset Writedown | -10,562 | -2,124 | -809 | -573 | - | Upgrade
|
| Pretax Income | 127,191 | 104,674 | 69,062 | 59,080 | 53,130 | Upgrade
|
| Income Tax Expense | 26,203 | 20,991 | 13,537 | 11,323 | 10,992 | Upgrade
|
| Net Income | 100,988 | 83,683 | 55,525 | 47,757 | 42,138 | Upgrade
|
| Net Income to Common | 100,988 | 83,683 | 55,525 | 47,757 | 42,138 | Upgrade
|
| Net Income Growth | 20.68% | 50.71% | 16.27% | 13.33% | 8.18% | Upgrade
|
| Shares Outstanding (Basic) | 4,454 | 4,483 | 4,531 | 4,593 | 4,668 | Upgrade
|
| Shares Outstanding (Diluted) | 4,463 | 4,495 | 4,545 | 4,606 | 4,680 | Upgrade
|
| Shares Change (YoY) | -0.71% | -1.10% | -1.34% | -1.58% | -1.63% | Upgrade
|
| EPS (Basic) | 22.67 | 18.67 | 12.26 | 10.40 | 9.03 | Upgrade
|
| EPS (Diluted) | 22.63 | 18.62 | 12.22 | 10.37 | 9.01 | Upgrade
|
| EPS Growth | 21.54% | 52.37% | 17.84% | 15.16% | 9.95% | Upgrade
|
| Free Cash Flow | 73,804 | 83,102 | 66,741 | 48,665 | 46,126 | Upgrade
|
| Free Cash Flow Per Share | 16.54 | 18.49 | 14.69 | 10.57 | 9.86 | Upgrade
|
| Dividend Per Share | 11.400 | 9.400 | 6.200 | 5.200 | 4.550 | Upgrade
|
| Dividend Growth | 21.28% | 51.61% | 19.23% | 14.29% | 8.98% | Upgrade
|
| Gross Margin | 85.00% | 84.79% | 83.94% | 83.20% | 83.51% | Upgrade
|
| Operating Margin | 48.17% | 45.08% | 42.73% | 42.06% | 42.64% | Upgrade
|
| Profit Margin | 34.78% | 36.03% | 31.38% | 33.92% | 33.19% | Upgrade
|
| Free Cash Flow Margin | 25.41% | 35.78% | 37.72% | 34.56% | 36.34% | Upgrade
|
| EBITDA | 146,669 | 110,523 | 81,119 | 63,770 | 58,565 | Upgrade
|
| EBITDA Margin | 50.51% | 47.59% | 45.84% | 45.29% | 46.13% | Upgrade
|
| D&A For EBITDA | 6,790 | 5,825 | 5,501 | 4,553 | 4,439 | Upgrade
|
| EBIT | 139,879 | 104,698 | 75,618 | 59,217 | 54,126 | Upgrade
|
| EBIT Margin | 48.17% | 45.08% | 42.73% | 42.06% | 42.64% | Upgrade
|
| Effective Tax Rate | 20.60% | 20.05% | 19.60% | 19.17% | 20.69% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.